UPP1 and Patent ductus arteriosus: To examine whether AMT can be used to treat other cancer-associated metabolic pathways, we upregulated the uridine phosphorylase 1 (UPP1) gene in human adipocytes and adipose organoids and tested whether they can suppress PDA, which is known to use uridine-derived ribose in glucose-restricted conditions35.